
Sign up to save your podcasts
Or


#nirbarzilai #humanlongevity #healthspan #agereversal #tame #metformin #livelong #livehealthier
Dr. Nir Barzilai is the founding director of the Institute for Aging Research, the Nathan Shock Center of Excellence in the Basic Biology of Aging and the Paul F. Glenn Center for the Biology of Human Aging Research at Albert Einstein College of Medicine of Yeshiva University
Dr Nir has studied over 600 centenarians to understand the biology and genetics of exceptional longevity. With this knowledge, Nir has spearheaded a randomized controlled trial of a medicine that interferes with the aging process to see if he can extend both the quantity and quality of life. TAME- is the worlds 1st FDA Approved anti-aging trial repurposing the drug #metformin & #rapamycin to control, stop & reverse aging.
Dr Nir is also the author of the Book, Age Later: HealthSpan, Life Span, and the New Science of Longevity
https://mstp.einstein.yu.edu/faculty/484/nir-barzilai/
https://www.cohbar.com/
By THE ONE'S CHANGING THE WORLD - future tech meets sustainability podcast in India#nirbarzilai #humanlongevity #healthspan #agereversal #tame #metformin #livelong #livehealthier
Dr. Nir Barzilai is the founding director of the Institute for Aging Research, the Nathan Shock Center of Excellence in the Basic Biology of Aging and the Paul F. Glenn Center for the Biology of Human Aging Research at Albert Einstein College of Medicine of Yeshiva University
Dr Nir has studied over 600 centenarians to understand the biology and genetics of exceptional longevity. With this knowledge, Nir has spearheaded a randomized controlled trial of a medicine that interferes with the aging process to see if he can extend both the quantity and quality of life. TAME- is the worlds 1st FDA Approved anti-aging trial repurposing the drug #metformin & #rapamycin to control, stop & reverse aging.
Dr Nir is also the author of the Book, Age Later: HealthSpan, Life Span, and the New Science of Longevity
https://mstp.einstein.yu.edu/faculty/484/nir-barzilai/
https://www.cohbar.com/